BFLY vs DXCM
BFLY: Butterfly Network provides portable, semiconductor-based ultrasound technology to make medical imaging more accessible and affordable globally. DXCM: Dexcom is a leading medical technology company specializing in continuous glucose monitoring (CGM) systems that help people with diabetes manage their condition with real-time data.
Side-by-side fundamentals
| Metric | BFLY | DXCM | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $7.07 | $83.45 | |
| Market cap as of 2026-08-03 | $1.9B | $31.5B | |
| P/E as of 2026-08-03 | n/a | 36.06 | |
| PEG as of 2026-08-03 | -5.40 | 1.41 | BFLY lower |
| Net margin as of 2026-08-03 | -73.7% | +19.3% | DXCM higher |
| Gross margin as of 2026-08-03 | +49.2% | +63.4% | DXCM higher |
| Operating margin as of 2026-08-03 | -79.5% | +21.4% | DXCM higher |
| ROE as of 2026-08-03 | -36.8% | +33.8% | DXCM higher |
| ROA as of 2026-08-03 | -25.6% | +13.4% | DXCM higher |
| Debt / equity as of 2026-08-03 | 0.00 | 0.44 | BFLY lower |
| Revenue growth (YoY) as of 2026-08-03 | +20.2% | +16.1% | BFLY higher |
| Revenue CAGR (3y) SEC XBRL | +10.0% | +17.0% | DXCM higher |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-08-03 | 2.10 | 0.78 | |
| 1-year return as of 2026-07-27 close | +258.9% | +3.3% | BFLY higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.